Janux Therapeutics
JANX
#7049
Rank
C$0.88 B
Marketcap
C$14.46
Share price
-2.04%
Change (1 day)
-64.40%
Change (1 year)

P/S ratio for Janux Therapeutics (JANX)

P/S ratio as of November 2026 (TTM): 26.3

According to Janux Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.6798. At the end of 2026 the company had a P/S ratio of 38.0.

P/S ratio history for Janux Therapeutics from 2021 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202638.0-53.76%
202582.1-72.6%
2024300388.82%
202361.3-3.81%
202263.7-71.77%
2021226